Vertical Integration Threat to Alma
Alma
This competition matters because Alma is not just fighting another therapist marketplace, it is fighting companies that already control the insurance contract, the referral path, and in some cases the clinician payroll. Alma helps independent therapists get credentialed, bill insurers, and fill schedules, but an incumbent like Optum can steer members from its health plan into its own behavioral care assets, while LifeStance owns the clinics, employs the clinicians, and captures the full visit economics inside one system.
-
Optum’s edge is structural. Alma depends on payer access, and Optum is both a payer partner and a care delivery owner. Alma already notes Optum restricted new Alma clinician credentialing in 2024, which shows how a vertically integrated incumbent can tighten network access while also owning behavioral capacity through Refresh.
-
LifeStance competes from the opposite direction. Instead of enabling independent therapists, it runs a scaled clinic network with 7,424 clinicians, 550 plus centers, and $1.25B of 2024 revenue. That gives it tighter control over scheduling, supervision, staffing, and payer relationships, but it comes with heavy center and labor costs.
-
The practical split in the market is asset light enabler versus asset heavy operator. Alma earns from membership fees and reimbursement take rates by giving therapists back office infrastructure. LifeStance and Optum can bundle care delivery with broader healthcare operations, which makes them harder to dislodge once referrals and insurance flows are wired in.
Going forward, the winners in mental healthcare will be the companies that own more of the patient and payer workflow. Alma is moving in that direction with psychiatry, AI documentation, and employer channels, but the market is likely to keep consolidating around platforms that either become indispensable infrastructure to independents or assemble enough clinical assets to behave like full care systems.